أفضل العلاج الكيميائي أخصائي أمراض الدم والأورام في أنقرة - توب -4 أطباء
الأستاذ المشارك الدكتور يوسف أجكجوز
التخصص: طب الأورام
تعليم:
- 2004-2011: كلية الطب بجامعة إينونو
- 2011-2016: مستشفى أنقرة نوموني للتدريب والبحث، الطب الباطني
- 2017-2022: جامعة العلوم الصحية، قسم الأورام الطبية
الخبرة المهنية:
- 2016-2017: مستشفى مدينة بينجول، الطب الباطني
- 2021-2022: جامعة العلوم الصحية، قسم الأورام الطبية
- 2022-2023: مستشفى كاستامونو للتعليم والبحث، قسم الأورام الطبية
- 2023-2024: جامعة ولاية أوهايو، قسم الأورام الطبية
- 2024-حتى الآن: جامعة لقمان حكيم، قسم الأورام الطبية، مستشفى أنقرة
التجارب السريرية، الدورات، الشهادات:
التجارب السريرية:
- 2017-2021: المرحلة الثالثة، دراسة CheckMate-649 (باحث مساعد)
- 2022-حتى الآن: المرحلة الثالثة، دراسة Fortitude-101 (باحث مساعد)
الدورات:
- 2018: برنامج تدريبي في الإحصاء الحيوي الأساسي والمتقدم من Medicres (جاري)، إسطنبول-فيينا
- 2019: دورة تعليمية في علم الأورام المناعي، 1-2 مارس 2019، فيينا، مجموعة الأورام التعاونية لأوروبا الوسطى (CECOG)
- 2018: شهادة الممارسة السريرية الجيدة، 7-8 أبريل 2018، أنقرة، جامعة العلوم الصحية
- 2017: برنامج تدريب أساسيات علم الأورام، 25-26 نوفمبر 2017، أضنة، جمعية علم الأورام السريرية
- 2016: دورة الموجات فوق الصوتية الأساسية (10 ساعات نظرية + 10 ساعات عملية)، 24-25 سبتمبر 2016، أنقرة، جمعية طب الطوارئ التركية
الشهادات:
- جاري: شهادة ECFMG
- 2024: السلوك المسؤول في الأبحاث في CITI (جامعة ولاية أوهايو)
- 2024: CITI IACUC-أبحاث الحيوانات المعملية (جامعة ولاية أوهايو)
- 2024: حماية الأشخاص الخاضعين للتجارب من خلال CITI (جامعة ولاية أوهايو)
- 2024: ممارسات CITI السريرية الجيدة (جامعة ولاية أوهايو)
- 2023: اختبار اللغة الإنجليزية المهنية (OET)
- 2019: نظام اختبار اللغة الإنجليزية الدولي (IELTS)، مجموع النقاط: 6.5، 26 مايو 2019، أنقرة، المجلس الثقافي البريطاني
- 2017: امتحان USMLE Step 2 CK؛ النتيجة: 244، 7 فبراير 2017
- 2016: امتحان USMLE الخطوة 1؛ النتيجة: 215، 25 أغسطس 2016
العضويات:
- الجمعية الأمريكية لعلم الأورام السريري (ASCO) - 2022
- الجمعية التركية لعلم الأورام الطبية - 2020
الاعتمادات:
Prof. Dr. Osman İLHAN graduated from Ankara University Faculty of Medicine in 1978. After completing his internal medicine residency at the same faculty in 1982, he served as a senior resident at the GATA Hematology Clinic during his military service. After completing his mandatory service at SSK Ulus Hospital, he returned to Ankara University Faculty of Medicine for a subspecialty. In 1990, he became an associate professor of hematology. He worked in Genoa, Italy to increase his knowledge and experience in leukemia. He was part of the team that performed the first bone marrow stem cell transplant in Turkey. In 1996, he went to the MD Anderson Cancer Center in the USA to work on "Stem Cell Mobilization, Cryopreservation, and Transplantation." In 1996, he became a professor of hematology. In 1999, he was elected as the regional president of ESFH (European Society for Hemapheresis). Dr. İlhan, who was the founder and president of the Hemapheresis Society in 2000, joined the World Apheresis Association (WAA) in 2001. He became the President of the Turkish Hematology Association in October 2001. Dr. İlhan, who is an active member of the European Hematology Association (EHA), was a member of the accreditation committee (ECAH) for education. He played a role in the accreditation of Turkish hematologists in CME credits by participating in the accreditation of congresses and courses held in Turkey as a Provider Status. He served as the founding president of the Cellular Therapy and Regenerative Medicine Association established in 2008. He became the founding president of the Geriatric Hematology Association in 2011. He is the Honorary President of the World Apheresis Congress (WAA) held in 2012. Dr. İlhan, who previously served on drug licensing and ethics committees at the Ministry of Health, has also served as the Chairman of the Photopheresis-Apheresis Commission and the Scientific Committee for Bone Marrow Transplantation, as well as the Chairman of the National Organ Tissue Cell Coordination Board, the Scientific Board of Cord Blood, and the Stem Cell Research Board. He is the founding president of the STEM CELL FOUNDATION and has played an important role in the establishment of TURKOK (Turkish Stem Cell Donor Bank). Dr. İlhan has over 300 publications in journals registered in PubMed and more than 5000 citations. He holds the Platinum CME certificate from the European Hematology Association. He owns four brands/patents named “Kökten Çözüm (Deep Solution), Telehematoloji (Telehematology), Hemaferez (Hemapheresis), Kanser Kök Hücresi (Cancer Stem Cell)”. He is currently the President of the Ankara Medical Association. Prof. Dr. Osman İlhan, who served at Ankara University Faculty of Medicine for 50 years, began working at Özel Koru Ankara Hospital as of January 1, 2023.
His medical interests include:
Hematopoietic Stem Cell Transplantation (Autologous, Allogeneic)
Acute Leukemia
Chronic Leukemia Treatments
Hodgkin Lymphoma
Non-Hodgkin Lymphoma Treatments
Multiple Myeloma Treatments, MDS
Aplastic Anemia
ITP
TTP Treatments
Hypercoagulability
Hereditary Thrombophilia Treatments
Therapeutic Apheresis
Photopheresis
Geriatric Hematology Diseases.
اقرأ المزيدAssociate Professor Dr. Emrah Eraslan graduated from Ankara University Faculty of Medicine in 2005. From 2006 to 2011, he worked as a research assistant in the Department of Internal Medicine at Ankara University Faculty of Medicine and became an internal medicine specialist in 2011. Between 2011 and 2013, he worked as an internal medicine specialist and chief physician at Dr. Nafiz Körez Sincan State Hospital and Palu District State Hospital. From 2013 to 2016, he received medical oncology training at Dr. Abdurrahman Yurtaslan Ankara Oncology Education and Research Hospital and worked there until 2021. In 2023, he became an associate professor and contributed to his field with his publications throughout his career. He currently serves his patients at Koru Ankara Hospital. His medical interests include:
Breast Cancer
Prostate Cancer
Lung Cancer
Colorectal Cancer
Stomach Cancer
Ovarian Cancer
اقرأ المزيد